AC Immune (ACIU) Receivables - Other (2016 - 2025)
AC Immune has reported Receivables - Other over the past 11 years, most recently at $1.2 million for Q4 2025.
- Quarterly Receivables - Other fell 2.9% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 2.9% year-over-year, with the annual reading at $1.2 million for FY2025, 2.9% down from the prior year.
- Receivables - Other was $1.2 million for Q4 2025 at AC Immune, down from $2.0 million in the prior quarter.
- Over five years, Receivables - Other peaked at $701.2 million in Q4 2023 and troughed at $288027.0 in Q1 2022.
- The 5-year median for Receivables - Other is $1.3 million (2024), against an average of $114.2 million.
- Year-over-year, Receivables - Other crashed 99.93% in 2022 and then skyrocketed 172228.97% in 2023.
- A 5-year view of Receivables - Other shows it stood at $464.2 million in 2021, then tumbled by 99.91% to $406904.6 in 2022, then skyrocketed by 172228.97% to $701.2 million in 2023, then crashed by 99.82% to $1.3 million in 2024, then decreased by 2.9% to $1.2 million in 2025.
- Per Business Quant, the three most recent readings for ACIU's Receivables - Other are $1.2 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).